Indaptus Therapeutics, Inc.
corporate_fare Company Profile
Indaptus Therapeutics, Inc. (NASDAQ:INDP) is a publicly traded company in the Life Sciences sector. Wiseek monitors INDP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- CEO's Stake Diluted to 8.44% Following Recent Private Placement
- Major Shareholder Yun Yao's Stake Diluted to 31.51% Following Recent Private Placement
- Selling Stockholders Register $72 Million in Common Stock for Resale
- Indaptus Therapeutics Secures $12M in Deeply Discounted Offshore Private Placement at $0.60/Share
- Indaptus Therapeutics Secures $12M in Deeply Discounted Private Placement
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for INDP, detected from its recent SEC filings · latest filing 2026-06-24.
$12 Million Private Placement Completed · Significant Discount and Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →